Immune responses against HCV-NS3 after accidental infection with HCV-NS3 recombinant vaccinia virus

Journal of Viral Hepatitis

Volumn 14, Issue 11, 2007, Pages 817-819

  Eisenbach, C ^a   Neumann Haefelin, C ^b   Freyse, A ^a   Korsukewitz T ^c   Hoyler, B ^a   Stremmel, W ^a   Thimme, R ^b   Encke, J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c Hospital of Biedenkopf   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADULT; ANALYTICAL EQUIPMENT; ANTIBODY SCREENING; CASE REPORT; CELLULAR IMMUNITY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DNA SEQUENCE; FINGER; HEPATITIS C VIRUS; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; INJECTION SITE INFECTION; INJECTION SITE NECROSIS; LETTER; NECROSECTOMY; NEEDLESTICK INJURY; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TRANSGENE; VACCINIA; VACCINIA VIRUS; VIRUS EXAMINATION; VIRUS GENE; VIRUS RECOMBINANT; VIRUS STRAIN; WESTERN BLOTTING;

ADULT; ANTIBODY FORMATION; HEPACIVIRUS; HUMANS; INTERFERON TYPE II; TH1 CELLS; VACCINES, SYNTHETIC; VACCINIA; VACCINIA VIRUS; VIRAL HEPATITIS VACCINES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 35248866895     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2007.00872.x     Document Type: Letter

References (17)

1. Afdhal NH. The natural history of hepatitis C. Semin Liver Dis 2004 24 (Suppl. 2 3 8.
2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005 5 : 558 567.
3. Fenner F. A successful eradication campaign. Global eradication of smallpox. Rev Infect Dis 1982 4 : 916 930.
4. Fauci AS. Bioterrorism: defining a research agenda. Food Drug Law J 2002 57 : 413 421.
5. Lane HC, Montagne JL, Fauci AS. Bioterrorism: a clear and present danger. Nat Med 2001 7 : 1271 1273.
6. Eisenbach C, Freyse A, Lupu CM et al. Multigenotype HCV-NS3 recombinant vaccinia viruses as a model for evaluation of cross-genotype immunity induced by HCV vaccines in the mouse. Vaccine 2006 24 : 5140 5148.
7. Neumann-Haefelin C, McKiernan S, Ward S et al. Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution. Hepatology 2006 43 : 563 572.
8. Folgori A, Capone S, Ruggeri L et al. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat Med 2006 12 : 190 197.
9. Nascimbeni M, Mizukoshi E, Bosmann M et al. Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 2003 77 : 4781 4793.
10. Shoukry NH, Grakoui A, Houghton M et al. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J Exp Med 2003 197 : 1645 1655.
11. Bassett SE, Guerra B, Brasky K et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 2001 33 : 1479 1487.
12. Grakoui A, Shoukry NH, Woollard DJ et al. HCV persistence and immune evasion in the absence of memory T cell help. Science 2003 302 : 659 662.
13. Cooney EL, Collier AC, Greenberg PD et al. Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet 1991 337 : 567 572.
14. Graham BS, Belshe RB, Clements ML et al. Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network. J Infect Dis 1992 166 : 244 252.
15. Jones L, Ristow S, Yilma T, Moss B. Accidental human vaccination with vaccinia virus expressing nucleoprotein gene. Nature 1986 319 : 543.
16. Cooney EL, McElrath MJ, Corey L, et al. Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein. Proc Natl Acad Sci USA 1993 90 : 1882 1886.
17. Seifert U, Liermann H, Racanelli V et al. Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 2004 114 : 250 259.